The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.
Could an emerging ultrasound guidance modality make challenging IV (intravenous) access a thing of the past for hospitalized patients?
Recognizing the frequent challenges with vessel visualization and access for IV placement in hospitalized patients, BD (Becton, Dickinson and Company) has launched the BD Prevue™ II Peripheral Vascular Access System, an ultrasound guidance modality that may improve the efficiency and safety of needlesticks for IV access.
BD said key features of the BD Prevue II Vascular Access System include:
• real-time needle depth markers;
• a specialized probe, which allows use of the technology without the clinician altering his or her field of view or current insertion technique;
• a virtual display of the needle trajectory with BD Cue™ Needle Tracking Technology; and
• vessel assessment tools that help ensure optimal IV catheter length.
“Difficult IV access remains far too common today, but the availability of the BD Prevue II (Vascular Access) System supports a future where every needle stick has a predefined pathway for successful placement,” noted Eric Borin, the worldwide president of Medication Delivery Solutions at BD. “ … First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence.”
BD added the BD Prevue Vascular Access System is compatible with BD Cue Needle Tracking-enabled catheters.
(Editor’s note: For a related article, see “Intravascular Ultrasound for Lower Extremity Interventions: Seven Takeaways for New Global Consensus Recommendations.”)
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.